Archive for the ‘research’ Category

Podcast: Why Lyme Disease Happens to Some People and Not Others

https://www.lymedisease.org/why-lyme-happens-some-not-others/  Go here for video

PODCAST: Why Lyme disease happens to some people and not others

By Fred Diamond

One of the most common questions I hear from Lyme survivors is simple but deeply loaded: “Why did this happen to me? Why did I get Lyme when others didn’t?”

If you’ve ever asked yourself, “Why me?” know that you’re not alone.

Thousands of Lyme survivors have pondered that same question. They were healthy. They were hiking. They were gardening. They were kayaking. They were simply living their lives. And then something changed.

On this week’s Love, Hope, Lyme podcast, Dr. Jennifer Miller of Galaxy Diagnostics, a scientist who has spent her career studying the Lyme bacterium, Borrelia burgdorferi, discusses why Lyme happens and why its effect may differ from person to person.

Her explanation reveals just how complex, and insidiously strategic, this organism truly is.

It starts in the wild

Lyme disease is what scientists call a vector-borne infection. In simple terms, that means it is transmitted by a vector and in this case, ticks.

But ticks are not born infected.

“The tick has to pick it up from a host that’s already infected,” Dr. Miller explains. “The larval tick will feed on an infected animal… and acquire the infection.”

That infected animal is usually a small mammal such as a mouse, chipmunk, or squirrel. These animals act as reservoir hosts. They carry the bacteria without becoming visibly sick.

After feeding, the tick molts into a nymph which is the stage most responsible for transmitting Lyme to humans. Nymphs are tiny, often no bigger than a poppy seed, and difficult to detect.

Many people assume deer are the main source of Lyme. Dr. Miller clarifies the nuance.

“Deer can have Lyme disease, but people aren’t going to get it from a deer.”

Deer play a role in the tick life cycle, but they are not the direct cause of human infection. The real issue is ecological.

“Because we have all these reservoir hosts, it’s a big part of the problem as to why Lyme disease incidence is increasing and why it’s spreading,” she says. “As humans, we occupy and consume more and more space… we’re encroaching on the territory of the deer, and with that, very unfortunately, comes Lyme disease.”

In other words, Lyme is not random. It is the byproduct of an expanding interface between humans and the natural infection cycle.

Borrelia is not an ordinary bacterium

Lyme disease is caused by a bacterium, not a virus, but it behaves unlike most bacteria.

Borrelia belongs to a family called spirochetes. It has a corkscrew shape that gives it unusual mobility.

“Borrelia will literally outrun the immune system,” Dr. Miller says. “Because it’s a corkscrew, it literally will burrow into the tissues.”

That corkscrew motion allows it to penetrate deeply into connective tissue, joints, and even cross protective barriers like the blood-brain barrier.

Even more concerning, Borrelia is highly adaptive.

“It literally will coat itself with host proteins. That allows it to evade immune detection.”

Camouflage

In essence, the bacterium can camouflage itself. It changes the proteins on its surface depending on whether it is inside a tick or inside a human. Once inside the body, it can alter its “coat” again to hide from immune surveillance.

Unlike some bacteria that cause disease by releasing toxins, Borrelia’s damage often comes indirectly.

“They’re not making toxins or poisons like other bacteria,” Dr. Miller explains. “But a lot of what happens with Borrelia is triggered by the immune system.”

The medical literature uses the phrase immune dysregulation to describe this phenomenon.

“Borrelia really interferes with the immune system,” she says.

In some individuals, the immune response becomes excessive and inflammatory, leading to joint damage, neurological symptoms, and widespread pain. In others, the immune response is blunted or misdirected, allowing the bacterium to persist quietly.

Why do some people get so sick while others don’t?

This may be the most painful question Lyme survivors ask.

“That’s still the biggest question that we need to answer,” Dr. Miller says candidly. “What I’ll tell you quite openly is that we don’t have all the answers.”

But there are clues.

Different strains of Borrelia produce slightly different surface proteins.

“Depending on which version of those proteins they’re making, some of those versions disagree with certain humans more than others.”

Some strains provoke a strong immune reaction. Others may slip past immune detection more easily.

Borrelia also actively interferes with antibody production.

“Borrelia will interfere with the timing of the antibody response. It interferes with the strength of the antibody response,” she explains. “It will trick them and confuse them so that they don’t produce antibodies in the right timeframe or of the right strength.”

This has enormous implications. If the immune system does not respond in a predictable way, both symptoms and laboratory tests become harder to interpret.

Host factors matter too. Genetics, previous infections such as Epstein-Barr virus, co-infections, mold exposure, chronic stress, and environmental burdens may all influence how a person responds.

There is likely no single reason why one person clears infection and another develops chronic symptoms. It is a complex interaction between pathogen and host.

The complication of co-infections

Lyme rarely travels alone.

“The number of different pathogens that were in the tick was far more than anybody would’ve thought… easily dozens,” Dr. Miller notes.

Ticks may carry Borrelia along with Babesia (a parasite similar in some ways to malaria), Bartonella (a different type of bacteria), Anaplasma, Ehrlichia, and even viral pathogens.

“You really have a lot of diversity of pathogens with these co-infections. That’s part of why they can be so very difficult to treat.”

A tick can acquire pathogens from one animal, survive the molt, then feed on another animal and acquire additional organisms. Birds, which can transport infected ticks across geographic regions, add another layer of complexity.

This microbial diversity means that two people bitten by ticks in different environments may experience very different symptom patterns.

Why testing fails so often

Few topics frustrate Lyme patients more than testing.

The standard two-tier antibody testing protocol has been in use for more than three decades. It measures antibodies but not the bacteria itself.

“The current tests are detecting that antibody response, and that can be very tricky,” Dr. Miller explains.

Antibodies only tell you that your immune system has seen the pathogen at some point. They do not reliably indicate active infection. And because Borrelia interferes with antibody production, some people never produce a strong enough response to meet diagnostic thresholds.

“Not everybody even generates an antibody response to Borrelia, one that’s strong enough or in line with what our out-of-date tests measure.”

False negatives can occur. Partial antibody bands may appear but not meet reporting criteria. Cross-reactivity with other infections can create additional confusion.

Adding to the challenge, Borrelia does not remain in high concentrations in the bloodstream.

“They don’t hide out at large numbers in the blood. There’s just not a lot of Borrelia in the blood.”

After transmission through the skin, the bacteria migrate into tissues. Blood-based detection becomes inherently difficult. This is why some researchers are working to develop direct detection methods, including antigen testing strategies.

“Borrelia are unique,” Dr. Miller explains. “When Borrelia shed their outer proteins it just gets released into the environment.”

Unlike many bacteria, Borrelia sheds structural components that may be detectable in other bodily fluids, offering a potential alternative to antibody-based testing.

A final word to patients

Lyme disease is biologically complex. It is ecologically driven. It is immunologically disruptive, and it does not behave like many other infections.

The science is still evolving. Researchers do not have all the answers.

But one thing is clear.

“If you think you have symptoms of Lyme disease and you haven’t seen a tick and you don’t have that bull’s-eye rash, please don’t assume that you don’t have Lyme disease,” Dr. Miller urges. “Go and get checked out.”

For survivors searching for understanding, the question why did this happen may never have a simple answer. But understanding biology, ticks, the bacterium, the immune system, and the co-infections can bring clarity.

And the more we understand that organism, the closer we move toward better diagnostics, better treatments, and better outcomes for every Lyme survivor.

Visit the Galaxy Diagnostics website to learn more about Lyme disease testing.

Click here to listen to all episodes of the Love, Hope, Lyme Podcast or on YouTube.

Coinfection in Lyme Disease: Clinical Impact, Diagnostic Challenges, and Therapeutic Perspectives

https://www.mdpi.com/2076-2607/14/2/325

Tick-Borne Co-Infection in Lyme Disease: Clinical Impact, Diagnostic Challenges, and Therapeutic Perspectives

by Georgi Popov, Dzhaner Bashchobanov* and Radina Andonova
Clinic of Infectious Diseases, Sofiamed Hospital, 1797 Sofia, Bulgaria
*Author to whom correspondence should be addressed.
Microorganisms 202614(2), 325; https://doi.org/10.3390/microorganisms14020325
Submission received: 8 January 2026 / Revised: 27 January 2026 / Accepted: 28 January 2026 / Published: 30 January 2026
Abstract
Tick-borne co-infections are an increasingly recognized and clinically important aspect of Lyme borreliosis, particularly in regions where Ixodes ticks transmit a wide range of bacterial, protozoan, and viral pathogens. In addition to Borrelia burgdorferi sensu lato, these ticks frequently harbor microorganisms such as Babesia spp.,   Anaplasma phagocytophilumEhrlichia spp., Borrelia miyamotoiBartonella spp., and several tick-borne viruses. Co-infections may increase disease severity, prolong symptom duration, and contribute to atypical or overlapping clinical presentations, thereby complicating diagnosis and management. Growing evidence from epidemiological studies, clinical case series, and experimental in vivo and in vitro models indicates that pathogen–pathogen and pathogen–host interactions can modulate immune responses and influence disease progression. Diagnostic challenges arise from non-specific clinical features and limitations of current laboratory methods. From a therapeutic perspective, although standard antibiotic regimens for Lyme disease are effective against some bacterial co-infections, they do not provide coverage for protozoan or viral agents, necessitating pathogen-specific and, in some cases, combination treatment strategies. This review synthesizes current knowledge on the epidemiology, clinical impact, diagnostic limitations, and treatment approaches for tick-borne co-infections associated with Lyme disease, and highlights critical evidence gaps and future research directions to improve patient outcomes.
For more:

Study: Unable to Produce ONE Case of Flu Despite Prolonged Close Contact But NIAID-Funded Scientists Engineer Mutant Flu Virus & ‘Expand its Host Range’

More on the ‘virus,’ ‘no virus,’ debate…..

https://jonfleetwood.substack.com/p/niaid-funded-scientists-tried-to?

NIAID-Funded Scientists Tried to Make Influenza Spread—They Couldn’t Despite 80+ Hours of Close Human Exposure: Journal ‘PLOS Pathogens’

Researchers engineered real-world transmission conditions using infected volunteers and sealed indoor exposure sessions, but no secondary infections were detected.

A new peer-reviewed study reports that researchers were unable to produce a single confirmed case of influenza transmission in a controlled human exposure experiment, despite prolonged close contact between infected individuals and healthy volunteers.

The study, published last month in PLOS Pathogens, tested whether naturally infected people could transmit influenza to others under tightly controlled indoor conditions designed to facilitate spread.

Transmission did not occur.

“[N]o transmission was observed in this study,” the authors confirm.

Researchers recruited individuals with confirmed influenza infection and placed them in repeated exposure sessions with healthy participants inside a sealed hotel-based quarantine environment.

Volunteers interacted face-to-face, shared objects, and spent hours together in a room with intentionally low ventilation—conditions chosen to support transmission.

Even under these circumstances, no recipient developed influenza-like illness, tested PCR-positive, or showed serological evidence of infection.  (See link for article)

_____________

**Comment**

Even the most hardened skeptic must scratch his head on this one.

Authors give possible reasons for the unexpected outcome:

  • the sick weren’t coughing enough
  • people had immune protection
  • airflow quickly diluted exhaled breath, reducing exposure

Fleetwood points out the exact same thing was found with COVID challenge studies. In other words, exposed volunteers failed to produce sustained infections.

This experiment has been repeated numerous times now showing the same result: nadda.  Going all the way back to the 1918 influenza pandemic, an experiment was conducted on 62 prisoners:

injected with infected lung tissue from sick or deceased patients, have infected tissue dropped in their eyes, and sprayed in the nose and mouth with infectious aerosols. Others would see mucus taken from critically ill patients and put it into the noses and throats of prisoners. In other parts of the trials, experimenters would take the blood of the sick and inject it into the healthy, to see if it was spread through infectious microorganisms in the blood.

Not one got ill or died.

What nobody is saying here is that viruses don’t exist.  But, there is a camp that asserts just that.  Go here for the history of this camp.  I would say these challenge studies don’t help the virus camp.

One thing is sure: exposure alone is not enough to make someone sick.

Which makes you wonder about the purpose of this……

https://jonfleetwood.substack.com/p/niaid-funded-scientists-engineer?

NIAID-Funded Scientists Engineer Mutant Influenza Virus and ‘Expand its Host Range’: Journal ‘Nature Communications’

Gain-of-function flu pathogen acquires new cell entry function, expands infection capability.

Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID) engineered influenza viruses and introduced mutations that expanded the virus’s host range—an outcome that the National Institutes of Health (NIH) itself formally defines as gain-of-function research under a 2025 Executive Order implementation notice.

The study, published in Nature Communicationslast week, confirms the work was funded through a NIAID influenza research center.

The authors state:

“Funding was also provided, in part, by … CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a National Institute of Allergy and Infectious Diseases (NIAID) funded Center for Influenza Research and Response (CEIRR, contract 75N93021C00014…).”

The CEIRR network is one of NIAID’s primary federally funded influenza research programs.

The current Director of NIAID—allowing such risky influenza lab engineering—is Dr. Jeffery Taubenberger, who holds a patent on the technology behind the Trump administration’s $500 million influenza vaccine platform.

The same federal agency funding the creation of mutated influenza viruses is led by the man who helped invent—and could profit from—the vaccine meant to fight them.

Moreover, the study comes as Congress and President Donald Trump have enacted a new law allocating more than $5.5 billion in taxpayer funding for pandemic preparedness, with influenza—the same pathogen engineered in these experiments—named as the only virus explicitly identified in the statute.

Funding for the experiment also came from the U.S. Department of Agriculture (USDA).

(See link for article)

______________

**Comment**

According to attorney Tom Renz, the scuttle that dangerous ‘gain of function’ research was recently banned due to an Executive Order, is false.  Rather, it’s codified and allowed under new regulation.  It’s all good if you are compliant with current regulation.

“Gain of Function” has now been legitimized and sanctioned.  Far from being banned.

The ‘no virus’ camp rolls their eyes at all of this because according to them, none of this exists.

Something exists and something is making people sicker than dogs. How about we find out what is causing these illnesses killing people and STOP funding research making pathogens deadlier?

For more:

Regarding Wisconsin:

 

 

Stealth Viruses as Biological Weapons in Vaccines

https://immunetolerance.substack.com/p/stealth-viruses-as-biological-weapons?

Stealth Viruses as Biological Weapons in Vaccines

How hidden viruses contaminating vaccines could be utilized as binary bioweapons for bioterrorism

Stealth is a very promising feature in biological weapons work, and it is a sought after characteristic in both the way they spread and the way they act on the host, which by its nature, has to be of the incapacitating agents that slowly tire, exhaust, and overwhelm the targets, rather than cause immediate deaths and overly apparent disease. Utilizing stealth agents with long incubation periods that can evade detection and disable the immune system were sought after in the Cold War, agents that were geared toward long-term attacks, so that by the time it is realized that such an agent is doing harm, it is often of such a late stage that is hard to correct or contain.

This is why the agents that cause slow chronic diseases became the most successful biological weapons during the Cold War, which is the focus of my first book The Sleeper Agent: The Rise of Lyme Disease, Chronic Illness, and the Great Imitator Antigens of Biological Warfare. In addition to that, all the better if they could find ways to introduce such viruses into the very medical technologies meant to prevent disease – the vaccine.

While contamination has plagued vaccine manufacturing as an inherent problem in the technology from its inception, the idea of deliberately tainting vaccines is not new in biowarfare history. In fact, even as far back as the Civil War the Confederates accused the North of deliberately tainting their smallpox vaccines with vaccino-syphilis.1  Sabotage of vaccines with specific agents was certainly known in potential and a very sensitive topic in the biological warfare race in motion since the start of the United States of America.2 By the time of the Cold War, the biological warfare race was in full swing and stealth agents were already being developed.

Erich Traub was the godfather of these stealth bioweapons – bioweapons that target the immune system, because it was Traub who discovered the mechanics of how they work when he discovered immune tolerance with LCM Virus beginning in 1935 at the Rockefeller Institute.3 Immune tolerance is chronic immunodeficiency, a paralyzed immune system.

These kinds of stealth agents were being unleashed on America and certainly vaccine contaminants would have been a highly esteemed method of infecting a population with stealth viruses that could cause chronic disease, mental illnesses, and cancers to explode in the decades to follow, which is exactly what we’ve seen, and its continued climbing ever since.

A 2003 declassified CIA assessment titled The Darker Bioweapons Future discusses the mechanisms of stealth viruses as biological weapons and talks about how an enemy could seed a population with a stealth virus that would remain dormant and be triggered later, as binary bioweapons that are effective through two components. It states:

According to the scientists convened, other classes of unconventional pathogens that may arise over the next decade and beyond include binary BW agents that only become effective when two components are combined (a particularly insidious example would be a mild pathogen that when combined with its antidote becomes virulent); “designer” BW agents created to be antibiotic resistant or to evade an immune response; weaponized gene therapy vectors that effect permanent change in the victim’s genetic makeup; or a “stealth” virus, which could lie dormant inside the victim for an extended period before being triggered. For example, one panelist cited the possibility of a stealth virus attack that could cripple a large portion of people in their forties with severe arthritis, concealing its hostile origin and leaving a country with massive health and economic problems.4

(See link for article)

____________

**Comment**

Finnegan does it again.  He dives deeply into forbidden territory showing the possibilities of what we are seeing all around us, and maybe experiencing personally.

He points out that vaccines are the perfect delivery system as they are designed to lower your immune system.  And it’s happened.  Cancer causing SV40 has been found polio vaccines (which exposed 200 million Americans) and in the COVID gene therapy injections.  

Finnegan points out how simple it all is to execute:  introduce stealth viruses into the animals to be used in the manufacture of ‘vaccines.’

Finnegan names names, and the chronologically shows very real connections of people and institutions – particularly that the FBI cleared Jonas Salk to advise the government to manufacture a polio vaccine when he couldn’t even pass a background check and was an active member of many communist front groups.  Further, he wrote books about overpopulation and stated we need to stop medical advances due to overpopulation. He also said viruses could be used to degenerate and test the gene pool of humanity (which the SV40 contaminated polio vaccine does).

In other words, he’s an outspoken eugenicist and feels more folks need help dying.
The SV40 problem still exists.

Important excerpt:

…..the FBI then clear[ed] Albert B. Sabin to team up with the Soviet bioweaponeer M. P. Chumakov, traveling back and forth between America and the Soviet Union to collaborate on a polio vaccine that would be given to many millions of Americans at a time when biowarfare activity between these countries was very active. M. P. Chumakov was very active in developing and testing biological weapons in the 1930s with ticks and other insects which they tested on the restive Muslim and Mongolian populations in Siberia. 

Highly recommended read.  It’s deep, but explains a lot.

For more:

 

 

Why Lyme Disease Can Feel Like PTSD

https://danielcameronmd.com/why-lyme-disease-can-feel-like-ptsd/

Why Lyme Disease Can Feel Like PTSD

11/25

A growing number of my patients tell me something they struggle to say out loud: “Why Lyme disease can feel like PTSD.” They describe a body that reacts like it’s in danger even when nothing is happening, a nervous system that fires alarms without a trigger, and symptoms that feel more like trauma physiology than traditional Lyme disease. This experience is real, biologically driven, and far more common than most clinicians recognize.


1. Why Lyme Disease Can Feel Like PTSD: When the Nervous System Misreads Signals

Lyme disease affects the brain regions responsible for threat detection — especially the amygdala, hippocampus, and autonomic fight-or-flight centers. When inflammation touches these circuits, the system can confuse normal sensations with danger, firing “protective” responses too early or too intensely.

Patients describe sudden adrenaline surges, waves of dread that appear without warning, air hunger, trembling, and nights filled with cortisol spikes. These trauma-pattern sensations occur not because of a traumatic event but because Lyme disrupts the same circuitry involved in PTSD-like responses. This is one of the main reasons why Lyme disease can feel like PTSD to so many patients.


2. PTSD-Like Lyme Symptoms Driven by Unpredictability

Lyme symptoms rarely follow a predictable path. Good days collapse without warning, flares strike suddenly, and stability feels fragile. Over time, the nervous system learns to anticipate danger even when nothing is happening.

One patient said, “The good days scare me the most because I don’t trust them,” and that captures how trauma physiology develops — not from one dramatic event, but from repeated internal unpredictability and the loss of safety in one’s own body.


3. Medical Dismissal Reinforces PTSD-Like Lyme Reactions

Invalidation intensifies trauma-like reactivity. Patients repeatedly hear:

  1. “Your tests are negative.”

  2. “This sounds like anxiety.”

  3. “You’re overthinking it.”

When someone already feels unsafe inside their own body, medical dismissal becomes another threat.
A patient once said, “The dismissal was more traumatizing than the illness,” and unfortunately this is a common experience. This medical trauma is part of why Lyme disease can feel like PTSD and why patients carry both physical and emotional wounds.


4. Trauma Without a Trauma Event: A Hallmark of PTSD-Like Lyme Symptoms

Lyme can create trauma physiology even without a traditional trauma event. No accident, no assault, no dramatic storyline — just:

  1. inflammation affecting the brain’s alarm system

  2. symptoms that appear and disappear without warning

  3. the nervous system learning from each flare

  4. loss of trust in one’s own body

  5. dismissal during the most vulnerable moments

Patients say, “My body remembers being sick,” or “My system reacts before I can think,” and these are accurate descriptions of a trauma-pattern nervous system responding to infection-driven disruption.


The Core Truth: Why Lyme Disease Can Feel Like PTSD

Lyme activates the same circuits trauma uses, disrupts the same autonomic pathways, and creates the same hypervigilance and internal alarms. The body braces for danger because the systems designed to sense danger have been altered by illness.

Patients are not imagining danger — their nervous system is responding to inflammation, unpredictability, and lived experience.

When we finally recognize this pattern, patients feel understood, and the nervous system can begin to settle after years of being on guard.

Have your Lyme symptoms ever felt like PTSD? Share your experience below — your story may help someone else feel less alone.


Resources

  1. National Institute of Mental Health. Traumatic Events and Post-Traumatic Stress Disorder (PTSD)
  2. Pubmed. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits
  3. Dr. Daniel Cameron: Lyme Science Blog. PTSD-Like Symptoms After Medical Gaslighting in Lyme Disease
  4. Dr. Daniel Cameron: Lyme Science Blog. What PTSD Research Reveals About Chronic Lyme Disease

_____________

**Comment**

Great article.  Thankfully, those days are long gone from me, but I remember them.

Lyme/MSIDS has a lot of unpredictability.  Patients often relapse.  This can set you up for holding your breath waiting for the shoe to drop!  This is no way to live but it takes time and experience to learn how to cope with this beast.

I’ve written this before, but it bares repeating – early on in my journey I found a patient online who had obtained their health back.  Please understand, I was desperate for hope!  Fighting the notion I would be sick forever, struggling with excruciating pain, I sent off an email asking their advice.  They got back to me immediately.  They ‘got it’ and understood my fear.  First, they told me I Could Get Well.  I can’t even begin to express the relief I felt.  But second, they told me to not get depressed about being depressed – that there were going to be hard days ahead, so just embrace the suck and know tomorrow could be much better.

I’m telling you, I would hug this person if they stood before me today.  They gave me hope and that is a medicine that is in short supply!

For more:

Lastly, I found I felt the worst mentally in tandem with feeling my worst physically.  This makes complete sense when you understand the systemic, widespread assault your body is battling.